Santos N R, Huston J P, Brandão M L
Laboratório de Psicobiologia, FFCLRP, Campus USP, Av. Bandeirantes 3900, 14049-901 Ribeirão Preto, SP, Brazil.
Pharmacol Biochem Behav. 2003 Apr;75(1):25-33. doi: 10.1016/s0091-3057(03)00033-9.
Electrical and chemical stimulation of the dorsal periaqueductal gray matter (dPAG) and the inferior colliculus (IC) induces escape behavior, usually accompanied by autonomic responses and antinociception. Recently, we presented evidence for a tonic inhibitory control exerted by H(2) histamine receptors on defensive behaviors generated in these midbrain tectum sites. Since treatments of these areas that elicit the defensive behavior repertoire frequently also have anxiogenic effects, we here used the elevated plus-maze (EPM) test for assessing the effects of microinjections of histamine (5-40 nmol), dimaprit (5-10 nmol) and ranitidine (10-30 nmol) into either dPAG or IC, which have a relative abundance of histamine-containing cells and histaminergic receptors. Dimaprit is an agonist and ranitidine is an antagonist of H(2) histamine receptors. Immediately after the injections, the animals were submitted to the EPM test. Whereas dPAG injections of dimaprit had no behavioral effects, histamine (40 nmol) caused a significant reduction in exploratory activity. On the other hand, ranitidine alone or following saline had aversive-like effects in both structures, i.e. reduced open arm, but not closed arm, entries. This pattern is usually interpreted as representing an anxiogenic effect. These effects were more pronounced after injection into dPAG than into IC. Freezing, the most prominent effect produced by ranitidine, was significantly inhibited by histamine as well as dimaprit. Thus, H(2) receptor blockade has fear-like action in the midbrain tectum with predominance in the dPAG. Such an action can be understood as a concomitant of defensive behavior, which has been shown to be a consequence of H(2) receptor antagonism in both dPAG and IC. The functional significance of the different effects of H(2) receptor blockade in dPAG and IC is discussed in the light of the probable distinct roles of these structures in the organization of defensive behavior.
对中脑导水管周围灰质背侧(dPAG)和下丘(IC)进行电刺激和化学刺激会诱发逃避行为,通常伴有自主反应和抗伤害感受。最近,我们提供了证据表明,H2组胺受体对这些中脑顶盖部位产生的防御行为发挥着持续性抑制作用。由于对这些引发防御行为组套的区域进行处理时,常常也会产生致焦虑效应,因此我们在此使用高架十字迷宫(EPM)试验,来评估向dPAG或IC微量注射组胺(5 - 40纳摩尔)、二甲双胍(5 - 10纳摩尔)和雷尼替丁(10 - 30纳摩尔)的效果,dPAG和IC中含有相对丰富的含组胺细胞和组胺能受体。二甲双胍是H2组胺受体激动剂,雷尼替丁是H2组胺受体拮抗剂。注射后立即对动物进行EPM试验。虽然向dPAG注射二甲双胍没有行为学效应,但组胺(40纳摩尔)会导致探索活动显著减少。另一方面,单独注射雷尼替丁或注射生理盐水后,在这两个结构中均产生类似厌恶的效应,即进入开放臂的次数减少,但进入封闭臂的次数未减少。这种模式通常被解释为代表致焦虑效应。这些效应在注射到dPAG后比注射到IC后更明显。雷尼替丁产生的最显著效应——僵住,被组胺以及二甲双胍显著抑制。因此,H2受体阻断在中脑顶盖具有类似恐惧的作用,在dPAG中更为突出。这种作用可被理解为防御行为的伴随现象,这已被证明是dPAG和IC中H2受体拮抗的结果。鉴于这些结构在防御行为组织中可能具有的不同作用,我们讨论了H2受体阻断在dPAG和IC中产生不同效应的功能意义。